News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Guilherme Nader Marta: Our meta-analysis looking at the prognostic value of ctDNA in early breast cancer is now out at ESMO Open
Photo from Guilherme Nader Marta/X
Mar 13, 2024, 23:46

Guilherme Nader Marta: Our meta-analysis looking at the prognostic value of ctDNA in early breast cancer is now out at ESMO Open

Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on LinkedIn:

“Our meta-analysis looking at the prognostic value of ctDNA in early breast cancer is now out at ESMO Open.

ctDNA is a strong prognostic factor in early breast cancer and its detection was associated with increased risk of recurrence and death. The association with worse outcomes was stronger when ctDNA was detected after treatment and by primary tumor-informed assays.

The mean lead time from ctDNA detection to overt recurrence was ~11 months.
ctDNA detection specificity for breast cancer recurrence was high (range 0.7 to 1.0) but sensitivity was lower (range 0.3 to 0.7).

Check it out.”

Guilherme Nader Marta: Our meta-analysis looking at the prognostic value of ctDNA in early breast cancer is now out at ESMO Open Guilherme Nader Marta: Our meta-analysis looking at the prognostic value of ctDNA in early breast cancer is now out at ESMO Open

Source: Guilherme Nader Marta/LinkedIn

Breast Cancer cancer ctDNA ESMO Open Guilherme Nader Marta OncoDaily Oncology
Special Coverage
Science
Apr 18, 2025, 16:18
Myeloma Paper of the Day, April 18th, suggested by Robert Orlowski
Blog
Apr 18, 2025, 15:43
ESGO - Tumour Board Webinar: Mechanisms of Drug Resistance: PARP, ADC, Immunotherapy
Blog
Apr 18, 2025, 15:37
Yin Weijie: Grateful for the opportunity to learn more about the advancements in cancer treatment
Blog
Apr 18, 2025, 15:32
Sbarro Health Research Organization - Has the time come to update surgical protocols for peritoneal tumors?
Blog
Apr 18, 2025, 15:31
Holden Culotta: Marty Makary’s FDA to remove big pharma insiders and end cruel animal testing
Radiotherapy
Apr 18, 2025, 15:25
Why Radiation Can Cause Hair Loss? Hair loss (Alopecia) and Radiotherapy
Blog
Apr 18, 2025, 15:15
Kevin Hall retires from the National Institutes of Health
Blog
Apr 18, 2025, 15:15
American Association for Cancer Research - How Will AI Impact the Future of Pathology?
Blog
Apr 18, 2025, 15:03
The Max Foundation - Thank you to everyone who attended 2025 Maximize Life Gala
Blog
Apr 18, 2025, 14:55
Sylvester Comprehensive Cancer Center is expanding access to world-class cancer care in Broward County
Oncolibrary
Apr 18, 2025, 14:48
New Paper Alert: Polygenic Risk Score Use Dramatically Improves Prostate Cancer Detection: Results from the BARCODE1 Study
Opinion
Apr 18, 2025, 14:42
Berta Marti Fuster: That’s a wrap on the 2025 Analog Devices' General Technical Conference